Viking Therapeutics, Inc.
VKTX
$35.63
$0.160.45%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 705.74M | 714.57M | 807.72M | 851.86M | 902.61M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.81M | 2.24M | 2.82M | 865.00K | 1.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.05M | 21.89M | 16.48M | 13.30M | 3.48M |
| Total Current Assets | 715.60M | 738.70M | 827.02M | 866.02M | 907.22M |
|
|
|||||
| Total Current Assets | 715.60M | 738.70M | 827.02M | 866.02M | 907.22M |
| Net Property, Plant & Equipment | 85.00K | 666.00K | 780.00K | 892.00K | 1.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 46.00K | 46.00K | 54.00K | 78.00K | 102.00K |
| Total Assets | 715.73M | 739.42M | 827.85M | 866.99M | 908.32M |
|
|
|||||
| Total Accounts Payable | 53.25M | 4.41M | 5.49M | 7.70M | 9.81M |
| Total Accrued Expenses | 23.28M | 21.22M | 26.02M | 11.37M | 17.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 137.00K | 437.00K | 468.00K | 498.00K | 489.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 76.67M | 26.07M | 31.98M | 19.57M | 27.41M |
|
|
|||||
| Total Current Liabilities | 76.67M | 26.07M | 31.98M | 19.57M | 27.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 318.00K | 410.00K | 502.00K | 630.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 76.67M | 26.39M | 32.39M | 20.08M | 28.04M |
|
|
|||||
| Common Stock & APIC | 1.49B | 1.40B | 1.39B | 1.38B | 1.37B |
| Retained Earnings | -847.55M | -689.88M | -599.10M | -533.54M | -487.91M |
| Treasury Stock & Other | 378.00K | 374.00K | -166.00K | -216.00K | -788.00K |
| Total Common Equity | 639.06M | 713.03M | 795.46M | 846.92M | 880.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 639.06M | 713.03M | 795.46M | 846.92M | 880.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 639.06M | 713.03M | 795.46M | 846.92M | 880.28M |
|
|
|||||